Our University appreciated by the MRA
18.11.2022
The Medical University of Gdańsk received the Award of the President of the Medical Research Agency Medicine of Tomorrow in the Institution category. The award was received by the Rector of our University Prof. Marcin Gruchała during the conference Medical Research Agency – impulse for the development of science, health and innovation. The event took place on 17th of November 2022 in Warsaw.
The Medical University of Gdańsk is one of the most active applicants receiving funding from the Medical Research Agency. Currently, the MUG is the leader of 16 projects financed by the MRA, among which 15 are research and scientific projects, and one concerns the creation of a Multidisciplinary Clinical Research Support Centre. The total value of the co-financing received from the MRA is over PLN 201 millions. More information on clinical trials conducted at the University is available on the website clinicalresearch.mug.edu.pl.
The award, presented for the first time, is aimed at recognizing people and institutions that have contributed the most to the development of the Polish healthcare system. In addition to our University, the following were honored: Prof. Anna Raciborska, head of the Department of Oncology and Oncological Surgery of Children and Adolescents at the Institute of Mother and Child in the category Principal Investigator and the Association of the Polish Group for the Treatment of Leukemia in Adults in the category Non-governmental organization.
In addition to the awards ceremony, the conference was devoted to innovations in healthcare. During it, the MUG’s Rector Prof. Marcin Gruchała, as the Chairman of the Conference of Rectors of Academic Medical Universities, took part in a discussion panel entitled Innovation is the future, during which strategic directions for the development of the health care system were discussed in the context of clinical trials. Our University was also represented by Prof. Piotr Czauderna, head of the Department of Surgery and Urology for Children and Adolescents, who, as the president of the Pediatric Surgery Section of the Union of European Medical Specialists, participated in the panel entitled 3-SEAS CANCER INITIATIVE – The Three Seas Initiative for Oncology. It concerned e.g. reduction of cancer mortality in the Three Seas Initiative, the main objectives of 3-SCI: prevention and early detection of cancer, its treatment and related education, and state-of-the-art research on this disease, as well as related international cooperation.